Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | February 27, 2023 01:30pm

Gainers

  • Lucira Health (NASDAQ:LHDX) stock increased by 255.5% to $0.5 during Monday's regular session. The current volume of 208.4 million shares is 2840.1% of Lucira Health's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $20.2 million.
  • ContraFect (NASDAQ:CFRX) stock rose 57.38% to $4.88. ContraFect's stock is trading at a volume of 23.4 million shares as of 12:30 EST. This is 14725.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.6 million.
  • Fortress Biotech (NASDAQ:FBIO) shares increased by 30.11% to $0.85. The current volume of 4.7 million shares is 878.6% of Fortress Biotech's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $108.7 million.
  • Concord Medical Services (NYSE:CCM) shares rose 23.3% to $1.27. The market value of their outstanding shares is at $55.1 million.
  • Acrivon Therapeutics (NASDAQ:ACRV) stock rose 21.98% to $18.7. The company's market cap stands at $390.5 million.
  • Erytech Pharma (NASDAQ:ERYP) shares rose 21.94% to $0.89. As of 12:30 EST, Erytech Pharma's stock is trading at a volume of 58.7K, which is 111.1% of its average full-day volume over the last 100 days. The company's market cap stands at $27.6 million.

Losers

  • Reata Pharmaceuticals (NASDAQ:RETA) shares decreased by 36.6% to $28.23 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 5.5 million shares, making up 794.6% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion.
  • Genprex (NASDAQ:GNPX) stock fell 15.08% to $1.16. Genprex's stock is trading at a volume of 1.2 million shares as of 12:30 EST. This is 381.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $55.4 million.
  • Cosmos Health (NASDAQ:COSM) stock decreased by 12.59% to $3.42. The current volume of 755.1K shares is 9.2% of Cosmos Health's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $36.2 million.
  • Vallon Pharmaceuticals (NASDAQ:VLON) shares fell 12.55% to $0.53. As of 12:30 EST, Vallon Pharmaceuticals's stock is trading at a volume of 785.4K, which is 9.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.1 million. As per the press release, Q4 earnings came out yesterday.
  • Applied Molecular (NASDAQ:AMTI) stock fell 12.52% to $0.57. As of 12:30 EST, Applied Molecular's stock is trading at a volume of 78.6K, which is 23.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.1 million.
  • Apexigen (NASDAQ:APGN) shares decreased by 12.31% to $1.14. Apexigen's stock is trading at a volume of 150.7K shares as of 12:30 EST. This is 7.2% of its average full-day volume over the last 100 days. The company's market cap stands at $28.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACRV AMTI APGN CCM CFRX COSM ERYP FBIO GNPX LHDX RETA VLON

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist